chr13-46782700-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_001984.2(ESD):c.348C>T(p.Thr116=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00537 in 1,612,056 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0039 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0055 ( 25 hom. )
Consequence
ESD
NM_001984.2 synonymous
NM_001984.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.260
Genes affected
ESD (HGNC:3465): (esterase D) This gene encodes a serine hydrolase that belongs to the esterase D family. The encoded enzyme is active toward numerous substrates including O-acetylated sialic acids, and it may be involved in the recycling of sialic acids. This gene is used as a genetic marker for retinoblastoma and Wilson's disease. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 13-46782700-G-A is Benign according to our data. Variant chr13-46782700-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 784270.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.26 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ESD | NM_001984.2 | c.348C>T | p.Thr116= | synonymous_variant | 6/10 | ENST00000378720.8 | |
ESD | XM_005266278.4 | c.348C>T | p.Thr116= | synonymous_variant | 6/10 | ||
ESD | XM_011534954.2 | c.348C>T | p.Thr116= | synonymous_variant | 6/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ESD | ENST00000378720.8 | c.348C>T | p.Thr116= | synonymous_variant | 6/10 | 1 | NM_001984.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00387 AC: 588AN: 151804Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
588
AN:
151804
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00282 AC: 707AN: 250682Hom.: 3 AF XY: 0.00261 AC XY: 354AN XY: 135494
GnomAD3 exomes
AF:
AC:
707
AN:
250682
Hom.:
AF XY:
AC XY:
354
AN XY:
135494
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00553 AC: 8075AN: 1460134Hom.: 25 Cov.: 30 AF XY: 0.00526 AC XY: 3821AN XY: 726368
GnomAD4 exome
AF:
AC:
8075
AN:
1460134
Hom.:
Cov.:
30
AF XY:
AC XY:
3821
AN XY:
726368
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00387 AC: 588AN: 151922Hom.: 2 Cov.: 32 AF XY: 0.00372 AC XY: 276AN XY: 74284
GnomAD4 genome
AF:
AC:
588
AN:
151922
Hom.:
Cov.:
32
AF XY:
AC XY:
276
AN XY:
74284
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 05, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | ESD: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at